Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Oct 03, 2022 11:23am
216 Views
Post# 35001573

RE:RE:RE:Near term impact on price

RE:RE:RE:Near term impact on price
Lesalpes29 wrote:
Infinity wrote: DJ,  I am so sure that we are negotiating from a position of weakness or out of desperation for cash flow.  I am not agains the current PP.  I wish the timing for the second PP had been phased out ove a 6 month time line.  Ideally,  after announcing the BTD application at a much higher price for both the shares and the warrants.  


Sometime it's difficult to believe that they want to get SP at the higher price possible.


Well heck, they need the money now to pay for GLP and the continuing Trial. Covid 19 chopped off about a years worth of finance $$, IMO. They did appear to keep this as small as possible. And the market could be back up in the .30s/.40s soon... :-) Not pushed by news even, just someone wanting a decent position...

<< Previous
Bullboard Posts
Next >>